Test will now be available for qualified laboratories across the European Union. Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19. "The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific....
Thermo Fisher Scientific Inc., the world leader in serving science, announced that on March 13, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19, and not for any other viruses or pathogens....
Avonchem’s clinically proven COVID-19 IgG/IgM Rapid Test is designed for initial screening by detecting anti-SARS-CoV-2 IgG and IgM antibodies in either human serum, plasma or whole blood within just 15 minutes. This test is easy-to-use, requires only minimally skilled personnel with basic equipment needs. This COVID-19 IgG/IgM Rapid Test has >94% sensitivity and 100% specificity making it one of the most effective screening tests for COVID-19...
Scientific Laboratory Supplies (SLS) and the Science Council have announced the cancellation of the Scientific Laboratory Show and Conference which was due to take place on May 20th 2020 at the East Midlands Conference Centre Nottingham. The UK’s biggest laboratory show and conference was expected to attract well over 1400 visitors plus over 70 exhibitors, Science Council member bodies and SLS personnel. After careful consultation and considering the development of the virus in the UK and Europe it was decided to cancel the event.....
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, has announced that it has been awarded circa £1 million by the Wellcome Trust and the Department for International Development (DFID), as part of the UK government’s £46 million international coronavirus (COVID-19) prevention and research funding package. The funding will be used by Mologic and global partners, to develop a point-of-need diagnostic test for the virus...
The organisers have decided to postpone ARABLAB+ 2020 due to the overwhelming concerns of a majority of exhibitors, visitors, principals and agents who normally attend the event over their ability to travel to the Show, and the Health & Welfare of their staff. They felt that they could not guarantee a successful exhibition with the number and quality of visitors that our exhibitors have normally come to expect.
Due to the increasing spread of the coronavirus (COVID-19) in Europe and on the basis of the recommendations of the Bavarian State Government as well as of the responsible health authorities, Messe München feels compelled to postpone analytica 2020. This measure is taken in consultation with the Exhibitors’ Advisory Board and in responsibility for the health of exhibitors and visitors. analytica will now take place from October 19 to 22, 2020.
The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain. These recombinant proteins offer scientists high-quality reagents to support ongoing infectious disease research, and the development of diagnostics and vaccines....
LGC’s SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostic manufacturers and clinical laboratories, is announcing the development of molecular reference materials for coronavirus utilizing their proprietary AccuPlex™ recombinant technology. The control material is being produced in collaboration with several diagnostic manufacturers to support development, evaluation, and validation of molecular test methods directed to 2019-nCoV....
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, has announced that it has completed principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intended to address potential need for detection of the virus. An outbreak of respiratory illness caused by the pneumonia-like 2019-nCoV has spread rapidly over the past two weeks, after first being discovered in the Chinese city of Wuhan...
Creative Diagnostics announced that it has launched a series of viral antigens for biological research use, including Adenovirus, CMV, Coronavirus, Coxsackievirus, Dengue Virus, EBV, EV71, Ebola Virus, HAV, HBV and so on. A virus antigen is a toxin or other substance given off by a virus which causes an immune response in its host. A viral protein is an antigen specified by the viral genome that can be detected by a specific immunological response....